Evidence map›Paper›PMID 27863502›Full record

ArticleVirology journal2016

Annexin A2 antibodies but not inhibitors of the annexin A2 heterotetramer impair productive HIV-1 infection of macrophages in vitro.

Andrew W Woodham, Adriana M Sanna, Julia R Taylor, Joseph G Skeate, Diane M Da Silva, Lodewijk V Dekker, W Martin Kast

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Annexin A2 in Virus Infection.Frontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Andrew W WoodhamWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Adriana M SannaNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Julia R TaylorDepartment of Molecular Microbiology & Immunology, University of Southern California, 1450 Biggy St., NRT 7507, Los Angeles, CA, 90033, USA.
Joseph G SkeateDepartment of Molecular Microbiology & Immunology, University of Southern California, 1450 Biggy St., NRT 7507, Los Angeles, CA, 90033, USA.
Diane M Da SilvaDepartment of Obstetrics & Gynecology, University of Southern California, Los Angeles, CA, USA.
Lodewijk V DekkerSchool of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, NG7 2RD, UK.
W Martin KastDepartment of Molecular Microbiology & Immunology, University of Southern California, 1450 Biggy St., NRT 7507, Los Angeles, CA, 90033, USA. Martin.Kast@med.usc.edu.
University of Southern California · USMassachusetts Institute of Technology · USUniversity of Nottingham · GB

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI William Dean Wallace · 1985 to 2026
$181.4M
VLP VACCINES AGAINST HPV INDUCED TUMORSR01CA074397 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KAST, WIJBE MARTIN · 1997 to 2020
$5.5M
Novel Pancreatic Cancer T Cell ImmunotherapyF32CA206330 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WOODHAM, ANDREW WALLACE · 2016 to 2016
$11k
Cancer Research UKNCI NIH HHS F32 CA206330NCI NIH HHS P30 CA014089NCI NIH HHS R01 CA074397
6 · The paper itself

Abstract

During sexual transmission of human immunodeficiency virus (HIV), macrophages are initial targets for HIV infection. Secretory leukocyte protease inhibitor (SLPI) has been shown to protect against HIV infection of macrophages through interactions with annexin A2 (A2), which is found on the macrophage cell surface as a heterotetramer (A2t) consisting of A2 and S100A10. Therefore, we investigated potential protein-protein interactions between A2 and HIV-1 gp120 through a series of co-immunoprecipitation assays and a single molecule pulldown (SiMPull) technique. Additionally, inhibitors of A2t (A2ti) that target the interaction between A2 and S100A10 were tested for their ability to impair productive HIV-1 infection of macrophages. Our data suggest that interactions between HIV-1 gp120 and A2 exist, though this interaction may be indirect. Furthermore, an anti-A2 antibody impaired HIV-1 particle production in macrophages in vitro, whereas A2ti did not indicating that annexin A2 may promote HIV-1 infection of macrophages in its monomeric rather than tetrameric form.

Indexed as

Host-Pathogen InteractionsVirus ReplicationAnnexin A2AntibodiesCentrifugationHIV-1HIV Envelope Protein gp120HumansImmunoprecipitationMacrophagesProtein BindingProtein Interaction MappingAnnexin A2AntibodiesANXA2 protein, humangp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Annexin A2Annexin A2 heterotetramerHIV-1InhibitorMacrophageReceptor

Identifiers

PMID27863502
PMCPMC5116172
OpenAlexW2554136304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.